Jun 2026 (Q1 FY27) — Jul 27, 2026
Agilysys Q1 FY27 — Record Sales, Revenue, and Profitability with Raised Full-Year Outlook
Read the full callAgilysys (AGYS) earnings
- Jun 2026
- Jun 2026 (Q1 FY27)
- Mar 2026
Agilysys earnings: last reported Mon, 27 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 87.7 | +14.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.1 | +5.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 9.0 | +83.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$113.42 +5.60% · +$6.01
Performance +1.2% 1Y
1Y: $112.06 on 14 Oct 2025 → $113.42. High $141.12 (28 Oct 2025), low $62.19 (10 Apr 2026).
- Previous close
- $107.41
- 52-week range
- $62.19 – $141.12
- One year
- +2.32%
Overview
- Symbol
- AGYS
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Agilysys earnings calls (AGYS)
Financials
What the filings say
Net profit, year on year: +84% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 68 | 70 | 74 | 77 | 79 | 80 | 83 | 88 |
| Operating profit | 4 | 7 | 5 | 5 | 14 | 12 | 13 | 10 |
| Operating margin | 6.0% | 10.7% | 7.2% | 5.9% | 17.8% | 14.6% | 15.2% | 11.1% |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 5 | 8 | 5 | 5 | 16 | 13 | 15 | 11 |
| Tax rate | 73.5% | 50.5% | 27.0% | −0.8% | 25.5% | 23.2% | 17.9% | 16.8% |
| Net profit | 1 | 4 | 4 | 5 | 12 | 10 | 12 | 9 |
| EPS ($ per share) | 0.05 | 0.14 | — | 0.18 | 0.42 | 0.35 | — | 0.32 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 |
| Reserves | 93 | 59 | 35 | 40 | 53 | 138 | 161 | 200 |
| Total liabilities | 63 | 83 | 110 | 117 | 134 | 114 | 168 | 155 |
| Fixed assets | 16 | 12 | 9 | 6 | 15 | 18 | 17 | 14 |
| Total assets | 164 | 155 | 190 | 214 | 243 | 350 | 434 | 482 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7 | 11 | 28 | 28 | 34 | 48 | 55 | 70 |
| Cash from investing | -6 | -3 | -1 | -26 | -7 | -8 | -149 | -2 |
| Cash from financing | -1 | -1 | 25 | -5 | -11 | -9 | 22 | -24 |
| Net cash flow | 1 | 6 | 53 | -2 | 16 | 32 | -72 | 44 |
| Capital expenditure | -3 | -3 | -1 | -1 | -7 | -8 | -3 | -2 |
| Free cash flow | 4 | 7 | 27 | 27 | 27 | 40 | 52 | 68 |
Insider filings
51 filings between Oct 27, 2025 and Sep 1, 2026.
Open market
decisions to buy or sellPurchases
$77.7K
16 purchases by 1 insider
Sales
$25.21M
18 sales by 7 insiders
11% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 1
- Award — granted as compensation
- 15
- Option exercise — converted options into shares
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| SRINIVASAN RAMESH | — | $21.29M | Aug 7, 2026 |
| Wood William David III | — | $1.58M | Aug 18, 2026 |
| Badger Kyle C | — | $1.30M | Aug 18, 2026 |
| COLVIN DONALD A | — | $739.7K | Nov 21, 2025 |
| Abdelrahman Joe Ahmed Youssef | — | $127.7K | Sep 1, 2026 |
| Robertson Chris J | — | $115.5K | Nov 12, 2025 |
| KEATING MELVIN L | $77.7K | — | Mar 17, 2026 |
| Shivashankar Sethuram | — | $61.9K | Nov 3, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Abdelrahman Joe Ahmed Youssef Chief Commercial Officer | Sale | 1,002 | $114.9K |
| Aug 18, 2026 | Badger Kyle C SVP, GC and Secretary | Sale | 8,400 | $958.1K |
| Aug 18, 2026 | Wood William David III Chief Financial Officer | Sale | 6,000 | $688.3K |
| Aug 7, 2026 | SRINIVASAN RAMESH President & CEO | Sale | 25,000 | $2.70M |
| Aug 6, 2026 | SRINIVASAN RAMESH President & CEO | Sale | 66,205 | $7.06M |
| Aug 6, 2026 | SRINIVASAN RAMESH President & CEO | Sale | 40,000 | $4.26M |
| Aug 5, 2026 | SRINIVASAN RAMESH President & CEO | Sale | 66,205 | $7.26M |
| Jun 10, 2026 | Badger Kyle C SVP, GC and Secretary | Sale | 1,000 | $92.5K |
| Jun 10, 2026 | Badger Kyle C SVP, GC and Secretary | Sale | 2,000 | $184.3K |
| May 26, 2026 | SRINIVASAN RAMESH President & CEO | Award | 7,570 | $0 |
| May 22, 2026 | Pope Lisa Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | MUTCH JOHN Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | KEATING MELVIN L Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | COLVIN DONALD A Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | Jones Dana Sue Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | JONES JERRY C Director | Option exercise | 973 | $77.7K |
| May 22, 2026 | Kaufman Michael A Director | Option exercise | 973 | $77.7K |
| Mar 17, 2026 | KEATING MELVIN L Director | Purchase | 70 | $4.8K |
| Mar 17, 2026 | KEATING MELVIN L Director | Purchase | 65 | $4.4K |
| Mar 17, 2026 | KEATING MELVIN L Director | Purchase | 50 | $3.4K |
| Mar 17, 2026 | KEATING MELVIN L Director | Purchase | 55 | $3.7K |
| Mar 16, 2026 | KEATING MELVIN L Director | Purchase | 60 | $4.1K |
| Mar 16, 2026 | KEATING MELVIN L Director | Purchase | 100 | $6.8K |
| Mar 10, 2026 | SRINIVASAN RAMESH President & CEO | Option exercise | 12,893 | $945.2K |
| Mar 10, 2026 | SRINIVASAN RAMESH President & CEO | Option exercise | 11,310 | $829.1K |
| Mar 10, 2026 | SRINIVASAN RAMESH President & CEO | Option exercise | 21,035 | $1.54M |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 40 | $3.4K |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 60 | $5.0K |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 30 | $2.5K |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 70 | $5.9K |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 50 | $4.1K |
| Feb 3, 2026 | KEATING MELVIN L Director | Purchase | 50 | $4.1K |
| Jan 30, 2026 | KEATING MELVIN L Director | Purchase | 50 | $4.2K |
| Jan 30, 2026 | KEATING MELVIN L Director | Purchase | 50 | $4.2K |
| Jan 30, 2026 | KEATING MELVIN L Director | Purchase | 100 | $8.5K |
| Jan 30, 2026 | KEATING MELVIN L Director | Purchase | 100 | $8.4K |
| Dec 4, 2025 | Jones Dana Sue Director | Gift | 2,810 | $0 |
| Nov 21, 2025 | COLVIN DONALD A Director | Sale | 6,000 | $739.7K |
| Nov 12, 2025 | Robertson Chris J Controller | Sale | 500 | $65.7K |
| Nov 4, 2025 | Wood William David III Chief Financial Officer | Sale 10b5-1 plan | 584 | $73.1K |
| Nov 3, 2025 | Shivashankar Sethuram CTO | Sale | 497 | $61.9K |
| Nov 3, 2025 | Badger Kyle C SVP, GC and Secretary | Sale | 502 | $62.6K |
| Nov 3, 2025 | Abdelrahman Joe Ahmed Youssef Chief Commercial Officer | Sale | 103 | $12.8K |
| Nov 3, 2025 | Robertson Chris J Controller | Sale | 400 | $49.9K |
| Nov 3, 2025 | Wood William David III Chief Financial Officer | Sale | 990 | $123.4K |
| Oct 31, 2025 | Abdelrahman Joe Ahmed Youssef Chief Commercial Officer | Option exercise | 419 | $52.6K |
| Oct 31, 2025 | Shivashankar Sethuram CTO | Option exercise | 723 | $90.7K |
| Oct 31, 2025 | Wood William David III Chief Financial Officer | Option exercise | 1,338 | $167.9K |
| Oct 31, 2025 | Badger Kyle C SVP, GC and Secretary | Option exercise | 622 | $78.0K |
| Oct 31, 2025 | Robertson Chris J Controller | Option exercise | 450 | $56.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for AGILYSYS INC
Free account. Everything above stays public.
Write why you follow AGILYSYS INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading